Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Clin Gastroenterol Hepatol
; 20(12): 2800-2808, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-34864158
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Hepatitis C
/
Hepatitis C, Chronic
/
Hepatitis B
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Clin Gastroenterol Hepatol
Year:
2022
Document type:
Article